How to Submit an FDA Briefing Document
A briefing document is a report sent to the Food and Drug Administration (FDA) that outlines a product's background, information to date and rationale for future development. The briefing document is submitted as part of an information packet for a meeting with the regulatory agency. It is a request for scientific advice and also guides the flow of a meeting with the FDA.
Instructions
Develop a timeline by working backwards based upon when you would like to meet with the FDA. The FDA will generally schedule a meeting approximately 60 days after the request is received. You will be required to submit the briefing document 30 days prior to the meeting date.
Submit a meeting request to the FDA, which informs the FDA of questions up for discussion and whom you believe should attend from the FDA. Each question should contain a brief background to provide context, if necessary for understanding of the question.
Establish the strategy of the briefing document and develop the context and background information around each of the questions. Ensure the document is clear, well-structured and provides an accurate and complete account of a product's status.
Submit the briefing document and information package to the FDA and distribute the material to all meeting attendees.
